Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RKUS
2376
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $794K | ﹤0.01% |
76,798
+19,036
| +33% | +$218K |
|
2377
Community Trust Bancorp
CTBI
$1.38B
| $791K | ﹤0.01% |
22,689
-34,917
| -61% | -$1.16M |
|
2378
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.9B
| $789K | ﹤0.01% |
12,230
+5,686
| +87% | +$376K |
|
|
LTS
2379
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $789K | ﹤0.01% |
225,453
+210,742
| +1,433% | +$745K |
|
|
VRNG
2380
DELISTED
VRINGO, INC COM STK NEW (DE)
VRNG
| $787K | ﹤0.01% |
141,743
+54,874
| +63% | +$356K |
|
2381
Old National Bancorp
ONB
$9.86B
| $786K | ﹤0.01% |
54,330
-12,761
| -19% | -$180K |
|
2382
StoneX
SNEX
$8.35B
| $786K | ﹤0.01% |
119,667
-70,324
| -37% | -$471K |
|
|
ASEI
2383
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $784K | ﹤0.01% |
+17,892
| New | +$774K |
|
|
GCVRZ
2384
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $784K | ﹤0.01% |
1,120,577
-205,300
| -15% | -$142K |
|
|
VRE
2385
DELISTED
Veris Residential
VRE
| $780K | ﹤0.01% |
42,320
-291,711
| -87% | -$5.31M |
|
|
HSTO
2386
DELISTED
Histogen Inc. Common Stock
HSTO
| $776K | ﹤0.01% |
+753
| New | +$883K |
|
2387
Fortune Brands Innovations
FBIN
$5.53B
| $771K | ﹤0.01% |
19,693
-1,161,979
| -98% | -$45.5M |
|
2388
Silgan Holdings
SLGN
$4.54B
| $766K | ﹤0.01% |
29,032
-108
| -0.4% | -$2.99K |
|
|
BMCH
2389
DELISTED
BMC Stock Holdings, Inc
BMCH
| $765K | ﹤0.01% |
+39,121
| New | +$733K |
|
|
SUSQ
2390
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
| $765K | ﹤0.01% |
+54,162
| New | +$752K |
|
2391
Brady Corp
BRC
$4.43B
| $761K | ﹤0.01% |
30,756
+6,253
| +26% | +$164K |
|
2392
ENI
E
$77.3B
| $761K | ﹤0.01% |
21,381
-141,607
| -87% | -$5.22M |
|
2393
Kemper
KMPR
$1.67B
| $761K | ﹤0.01% |
+19,751
| New | +$746K |
|
|
GPL
2394
DELISTED
Great Panther Mining Limited
GPL
| $760K | ﹤0.01% |
176,831
+139,511
| +374% | +$736K |
|
|
BGC
2395
DELISTED
General Cable Corporation
BGC
| $759K | ﹤0.01% |
38,478
-196,357
| -84% | -$3.65M |
|
2396
Artivion
AORT
$1.33B
| $758K | ﹤0.01% |
67,167
-95,662
| -59% | -$1.02M |
|
|
AGN
2397
DELISTED
Allergan plc
AGN
| $757K | ﹤0.01% |
2,493
-524,784
| -100% | -$157M |
|
|
MPG
2398
DELISTED
Metaldyne Performance Group Inc.
MPG
| $757K | ﹤0.01% |
41,732
+4,379
| +12% | +$83K |
|
2399
Alamo Group
ALG
$2.01B
| $754K | ﹤0.01% |
13,808
-3,746
| -21% | -$215K |
|
2400
First Busey Corp
BUSE
$2.49B
| $753K | ﹤0.01% |
38,217
+7,671
| +25% | +$149K |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.